Navigation Links
New Breast MRI Technology Enables Enhanced Breast Cancer Detection
Date:11/30/2009

GAINESVILLE, Fla., Nov. 30 /PRNewswire/ -- The launch of Invivo Corporation's ONCAD for DynaCAD marks the availability of the first FDA-cleared, fully-automated morphological system for the detection and analysis by a radiologist of suspicious breast lesions. The ONCAD system will be officially unveiled at the Radiological Society of North America 2009 Annual Meeting in Chicago.

Developed in partnership with leading experts in breast MRI, ONCAD for DynaCAD uses a patented mathematical algorithm to analyze the entire breast and draw a physician's attention to abnormal morphology during a contrast-enhanced breast MRI. ONCAD's fractal mathematics and proprietary algorithms not only enhance the detection of both invasive and noninvasive lesions, the approach also delineates the extent of the disease by measuring margin sharpness to determine the degree of lesion vascularization. The suspicious lesions are marked with a color overlay, light pink for moderate suspicion and dark pink for highly suspicious lesions, an important data point in a physician's assessment.

Studies have shown that while breast MRI procedures are cost-effective screening methods for high-risk patients and have a higher sensitivity than mammography, the numerous images generated have low specificity. ONCAD provides physicians with an objective quantification of the margins of suspicious lesions by employing shape- and texture-based filters to improve specificity. The results are seamlessly integrated in an automated DynaCAD hanging. Because ONCAD provides physicians with more visual information, they are able to detect suspicious lesions that may be imperceptible to the human eye, thereby improving their diagnostic confidence.

An Era of Innovation

The introduction of ONCAD for DynaCAD is one of several advanced clinical solutions recently brought to market by Invivo Corporation. Early this year, Invivo unveiled their DynaCAD for Prostate solution, combining new analysis and interventional options for patients with elevated or rising PSA levels and negative TRUS-guided biopsy results. DynaCAD for Prostate provides the physician with a comprehensive, customizable set of visualization tools for performing realtime analysis of prostate MRI studies. DynaCAD for Prostate and DynaTRIM then enable a physician to conduct targeted MRI interventions of suspicious areas within the prostate gland, reducing the number of cores acquired during biopsy. Compared to published cancer yield rates of up to 15% with third TRUS-guided biopsies, DynaCAD for Prostate produces a 59% detection rate with a maximum of 4 MRI-guided biopsy cores.

In 2009, Invivo Corporation announced the release of three new technologies: their Luminescence Breast Coil System, DynaCAD version 2.1 with QuickClick Segmentation, and DynaSuite Neuro Advanced MR Workstation.

  • Having been an industry leader in the development of MR breast coils, Invivo designed the Luminescence Breast Coil System, a modular diagnostic and interventional coil set that delivers improved image uniformity and performance and superior signal to noise ratio. The 16-channel system answers the demand for the best quality images, best ease of use and best patient experience as breast MRI procedures increase for screening high-risk populations.
  • DynaCAD version 2.1 with QuickClick Segmentation was previewed at the RSNA Annual Meeting in 2008. The software platform maintains the core functionalities that built DynaCAD's reputation for speed, power and flexibility and features quantification tools, rendering, and BI-RADS® Reporting, making it easier for a physician to read MRI studies and generate reports. QuickClick Segmentation offers a visualization system with automated site-specific measurements, snapshots and finding reports while maintaining the ability for a physician to customize their reading and reporting style.
  • DynaSuite Neuro Advanced MR Workstation is a high performance solution for the rapid and repeatable interpretation of MR Neuro images. The solution is capable of integrating anatomical, fMRI, and 3D vascular imaging with basic analysis to produce a dynamic, 3D model within the SmartFusion(TM) review.

About Invivo Corporation

Invivo Corporation has an over 20-year history as the pioneer of progressive MRI coils, advanced clinical visualization systems, and innovative MRI-compatible interventional devices. Invivo successfully designs, manufactures and markets high-value-added medical instruments that enhance MR image quality, improving physicians' diagnostic confidence and patients' imaging experience.

SOURCE Invivo Corporation


'/>"/>
SOURCE Invivo Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Survival differences by race most apparent in advanced stages of breast cancer
2. MRI finds breast cancer before it becomes dangerous
3. Pathway links inflammation, angiogenesis and breast cancer
4. Drop in breast cancer incidence linked to hormone use, not mammograms
5. Breast cancer prevention practices vary across Canada
6. Eating junk food whilst pregnant and breastfeeding may lead to obese offspring
7. Acrylamide Wont Raise Breast Cancer Risk
8. New link between estrogen and breast cancer
9. Hypnosis Eases Pain of Breast Cancer Surgery
10. Discovery suggests location of genes for breast density, a strong risk factor for breast cancer
11. Longaberger Expands Horizon of Hope Campaign to Build Support for American Cancer Societys Breast Cancer Initiatives
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2017)... Wheaton, IL (PRWEB) , ... July 28, 2017 , ... ... recently announced the hiring of associate Jennifer M. Cusack. Ms. Cusack joins ... areas. , Ms. Cusack graduated from Bradley University in Peoria, Illinois, with ...
(Date:7/28/2017)... (PRWEB) , ... July 28, 2017 , ... ... protection and financial planning assistance to families and business owners in and around ... to be held in honor of the Make-A-Wish Foundation. , The Make-A-Wish Foundation ...
(Date:7/27/2017)... ... July 27, 2017 , ... Dr. Adam ... of Oral Implantology/Implant Dentistry (ABOI/ID). After successfully completing an extensive two-day examination in ... dental implants . Dr. Kimowitz and his partner Dr. Hal Kimowitz, practice ...
(Date:7/27/2017)... ... 27, 2017 , ... TransPanel Volume 4 is a collection of animating panel ... exclusive features transitions that contain between 2 and 6 animated panels. Change the direction ... menus. TransPanel Volume 4 makes editing easy in Final Cut Pro X. , TransPanel ...
(Date:7/27/2017)... , ... July 27, 2017 , ... ... services, announces the internal promotion of Elrene Clinkscales to Vice President of Revenue ... & Remittance Management, reporting to Derek Morkel, chief executive officer (CEO). , Elrene ...
Breaking Medicine News(10 mins):
(Date:7/26/2017)... , July 26, 2017 Sancilio Pharmaceuticals ... of our clinical trial evaluating Altemia TM , an ... (SCA) and Sickle Cell Disease (SCD). The SCOT Trial, ... the efficacy and safety of Altemia TM in ... conducted under US IND 125274. ...
(Date:7/24/2017)... July 24, 2017 IBM (NYSE: IBM ) ... Quadrant for Solid-State Arrays (SSA) for the fourth year in ... According to Gartner, "Vendors in the Leaders quadrant have the ... Vision. A vendor in the Leaders quadrant has the market ... the acceptance of new technologies. These vendors demonstrate a clear ...
(Date:7/21/2017)... , July 21, 2017  Endo International plc ... completing a comprehensive review of its manufacturing network, the ... and distribution facilities in Huntsville, Alabama ... take place over the next 12 to 18 months. ... impacted by declining volumes of commoditized products and these ...
Breaking Medicine Technology: